Tarsus Pharmaceuticals (TARS) Tax Provisions (2020 - 2026)
Tarsus Pharmaceuticals' (TARS) quarterly Tax Provisions came in at $2.4 million in Q1 2026, up 48100.0% quarter-over-quarter from -$5000.0 in Q3 2022.
Tarsus Pharmaceuticals (TARS) Tax Provisions (2020 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Tax Provisions history runs 4 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.1 million, changed N/A from the prior year.
- Tax Provisions improved to $2.4 million in Q1 2026 per TARS's latest filing, from -$5000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $2.4 million in Q1 2026 and bottomed at -$5000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn | 2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40 Mn |
| Sep 30, 2022 | -5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | -341,000.00 |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 313,000.00 |
| Sep 30, 2020 | 1,000.00 |